Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer

Annals of the Royal College of Surgeons of England

Volumn 96, Issue 7, 2014, Pages 543-546

  Chand, Manish ^a   Swift, R I ^b   Chau, I ^a   Heald, R J ^c   Tekkis, P P ^a   Brown, G ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b CROYDON HEALTH SERVICES NHS TRUST   (United Kingdom)

^c PELICAN CANCER FOUNDATION   (United Kingdom)

Author keywords

Adjuvant chemotherapy; Extramural venous invasion; Rectal cancer

Indexed keywords

ADJUVANT CHEMOTHERAPY; CLINICAL PRACTICE; COLON RESECTION; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DECISION MAKING; FEMALE; HEALTH CARE SURVEY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROGNOSIS; QUESTIONNAIRE; RISK ASSESSMENT; SECONDARY; TREATMENT OUTCOME; TRENDS; TUMOR INVASION; UNITED KINGDOM; VASCULAR NEOPLASMS;

CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; DECISION MAKING; FEMALE; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM INVASIVENESS; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; QUESTIONNAIRES; RISK ASSESSMENT; TREATMENT OUTCOME; VASCULAR NEOPLASMS;

EID: 84907204564     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588414X13814021678835     Document Type: Article

References (28)

1. Wolmark N. Adjuvant therapy for colorectal cancer: the NSABP clinical trials. Adv Exp Med Biol 1988; 244: 261-266.
2. Fisher B, Wolmark N, Rockette H et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80: 21-29.
3. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992; 10: 549-557.
4. Wu X, Zhang J, He X et al. Postoperative adjuvant chemotherapy for stage II colorectal cancer: a systematic review of 12 randomized controlled trials. J Gastrointest Surg 2012; 16: 646-655.
5. Petersen SH, Harling H, Kirkeby LT et al. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev 2012; 3: CD004078.
6. Grinnell RS. The lymphatic and venous spread of carcinoma of the rectum. Ann Surg 1942; 116: 200-216.
7. Grinnell RS. The spread of carcinoma of the colon and rectum. Cancer 1950; 3: 641-652.
8. Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958; 12: 309-320.
9. Gilbertsen VA. Adenocarcinoma of the rectum. Ann Surg 1960; 151: 340-348.
10. Moossa AR, Ree PC, Marks JE et al. Factors influencing local recurrence after abdominoperineal resection for cancer of the rectum and rectosigmoid. Br J Surg 1975; 62: 727-730.
11. Talbot IC, Ritchie S, Leighton MH et al. The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980; 67: 439-442.
12. Knudsen JB, Nilsson T, Sprechler M et al. Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis Colon Rectum 1983; 26: 613-617.
13. Freedman LS, Macaskill P, Smith AN. Multivariate analysis of prognostic factors for operable rectal cancer. Lancet 1984; 2: 733-736.
14. Messenger DE, Driman DK, Kirsch R. Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome. Hum Pathol 2012; 43: 965-973.
15. Smith NJ, Barbachano Y, Norman AR et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008; 95: 229-236.
16. Royal College of Pathologists. Dataset for Colorectal Cancer (2nd Edition). London: RCPath; 2007. p26.
17. Taylor FG, Quirke P, Heald RJ et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 2011; 253: 711-719.
18. Shihab OC, Taylor F, Salerno G et al. MRI predictive factors for long-term outcomes of low rectal tumours. Ann Surg Oncol 2011; 18: 3,278-3,284.
19. Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1,731-1,740.
20. van Gijn W, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12: 575-582.
21. O'Connell MJ, Martenson JA, Wieand HS et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994; 331: 502-507.
22. Bujko K, Glynne-Jones R, Bujko M. Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials. Ann Oncol 2010; 21: 1,743-1,750.
23. Gray R, Barnwell J, McConkey C et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370: 2,020-2,029.
24. Quirke P, Morris E. Reporting colorectal cancer. Histopathology 2007; 50: 103-112.
25. Maughan NJ, Morris E, Forman D, Quirke P. The validity of the Royal College of Pathologists' colorectal cancer minimum dataset within a population. Br J Cancer 2007; 97: 1,393-1,398.
26. Morris EJ, Maughan NJ, Forman D, Quirke P. Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist. J Clin Oncol 2007; 25: 2,573-2,579.
27. Chand M, Swift RI, Tekkis PP et al. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer 2014; 110 (1): 19-25.
28. Chand M, Bhangu A, Wotherspoon A et al. EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy. Ann Oncol 2014; 25 (4): 858-863.